Financial statements Cytokina

Balance sheet of Cytokina

Company age:
Age:
8 y. 3 m. 7 d.
Share capital:
Share capital:
100 000 PLN

Balance sheet data of CYTOKINA

Year
2019
2020
2021
2022
2023
Total assets 727 678,72 666 853,49 484 135,68 417 733,18 886 347,11
A. Fixed assets 693 278,24 621 436,37 9 000,00 0,00 0,00
B. Current assets 34 400,48 45 417,12 475 135,68 417 733,18 886 347,11
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 727 678,72 666 853,49 484 135,68 417 733,18 886 347,11
A. Equity 571 028,66 377 348,82 414 991,99 319 922,50 283 370,94
B. Liabilities and provisions for liabilities 156 650,06 289 504,67 69 143,69 97 810,68 602 976,17
I. Long-term liabilities 0,00 0,00 0,00 66 665,94 66 665,94
II. Short-term liabilities 156 650,06 279 904,67 69 143,69 31 144,74 536 310,23
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.